Skip to main content
Clinical Trials/NCT04477863
NCT04477863
Recruiting
Not Applicable

Follow-up With Preimplantation Genetic Testing Patients

Genomic Prediction Inc.1 site in 1 country10,000 target enrollmentJuly 11, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
Genomic Prediction Inc.
Enrollment
10000
Locations
1
Primary Endpoint
Patient perspectives on PGT
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.

Detailed Description

Purpose: To perform longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT. Background: Preimplantation Genetic Testing (PGT) is a commercially available adjunct to in vitro fertilization (IVF) and is now performed in over 40% of treatment cycles in the United Sates (Society for Assisted Reproductive Technology Annual Report, 2018). Several clinical genetics entities offer PGT services, including Genomic Prediction Clinical Laboratory (CLIA# 31D2152380, CAP# 8488628). It is common practice to perform interviews with, and record reviews of patients following clinical interventions. Results may provide instrumental information for the scientific and medical community to improve clinical care. We would like to review medical records in order to recruit patients to participate in longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT. Study Design and Methods: Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. Patients who opted out of participating in research during informed consent to perform PGT will be ineligible for inclusion. Clinical PGT consent forms will be reviewed to identify patients that indicated willingness to participate in research. Eligible patients will be counseled on the study and consented for participation by a licensed genetic counselor. A total of 10,000 patients will be recruited. Following patient recruitment and informed consent, patient records and results of patient interviews may be used for publication in peer-reviewed scientific journals, presentation at scientific conferences or company meetings. As it is in standard practice, all external communication of results will maintain de-identification of all protected health information of all subjects (HIPAA guidelines). A licensed genetic counselor will conduct a recorded interview. Patient PGT, family history, and ethnicity data and information may be included in cohort analyses.

Registry
clinicaltrials.gov
Start Date
July 11, 2020
End Date
December 31, 2050
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients indicating willingness to participate in research during informed consent to perform PGT

Exclusion Criteria

  • Patients who opted out of participating in research during informed consent to perform PGT

Outcomes

Primary Outcomes

Patient perspectives on PGT

Time Frame: 2 years

Analysis of interview responses

Study Sites (1)

Loading locations...

Similar Trials